The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(2-(4'-Chloro-3'-(piperidin-4-yloxy)-[1,1'-biphenyl]-3-carboxamido)phenyl)acetic acid ID: ALA4745252
PubChem CID: 162648855
Max Phase: Preclinical
Molecular Formula: C26H25ClN2O4
Molecular Weight: 464.95
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)Cc1ccccc1NC(=O)c1cccc(-c2ccc(Cl)c(OC3CCNCC3)c2)c1
Standard InChI: InChI=1S/C26H25ClN2O4/c27-22-9-8-18(15-24(22)33-21-10-12-28-13-11-21)17-5-3-6-20(14-17)26(32)29-23-7-2-1-4-19(23)16-25(30)31/h1-9,14-15,21,28H,10-13,16H2,(H,29,32)(H,30,31)
Standard InChI Key: CNMYDAVATJWRII-UHFFFAOYSA-N
Molfile:
RDKit 2D
33 36 0 0 0 0 0 0 0 0999 V2000
16.6478 -17.6191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6467 -18.4386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3547 -18.8476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0644 -18.4382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0616 -17.6155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3529 -17.2102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3564 -19.6626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6470 -20.0704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6464 -20.8869 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3546 -21.2965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0647 -20.8836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0618 -20.0686 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7677 -17.2042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4770 -17.6102 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.7646 -16.3871 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.3554 -22.1136 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
20.1831 -17.1989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8908 -17.6082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5965 -17.1977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5938 -16.3796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8796 -15.9738 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1769 -16.3868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8918 -18.4254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6001 -18.8331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6011 -19.6503 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.3072 -18.4236 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.7738 -21.2899 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.4801 -20.8790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1837 -21.2891 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8879 -20.8817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8895 -20.0641 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.1806 -19.6557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4702 -20.0648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
3 7 1 0
5 13 1 0
13 14 1 0
13 15 2 0
10 16 1 0
14 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
18 23 1 0
23 24 1 0
24 25 2 0
24 26 1 0
11 27 1 0
27 28 1 0
28 29 1 0
28 33 1 0
29 30 1 0
30 31 1 0
31 32 1 0
32 33 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 464.95Molecular Weight (Monoisotopic): 464.1503AlogP: 5.02#Rotatable Bonds: 7Polar Surface Area: 87.66Molecular Species: ZWITTERIONHBA: 4HBD: 3#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 1CX Acidic pKa: 3.77CX Basic pKa: 9.82CX LogP: 1.97CX LogD: 1.97Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.46Np Likeness Score: -0.70
References 1. Velcicky J,Wilcken R,Cotesta S,Janser P,Schlapbach A,Wagner T,Piechon P,Villard F,Bouhelal R,Piller F,Harlfinger S,Stringer R,Fehlmann D,Kaupmann K,Littlewood-Evans A,Haffke M,Gommermann N. (2020) Discovery and Optimization of Novel SUCNR1 Inhibitors: Design of Zwitterionic Derivatives with a Salt Bridge for the Improvement of Oral Exposure., 63 (17): [PMID:32856916 ] [10.1021/acs.jmedchem.0c01020 ]